INHIBITEURS DE MIR-155 POUR LE TRAITEMENT DU LYMPHOME CUTANÉ À CELLULES T (CTCL)

• 收藏
• 分享

专利权人:

Miragen Therapeutics; Inc.

发明人:

申请号：

EP16804580.5

公开号：

EP3303590A4

申请日:

2016.06.03

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

The present invention provides oligonucleotide inhibitors of miR-155 and compositions thereof. The invention further provides methods for treating cancer such as a T cell lymphoma in a subject by administering to the subject an oligonucleotide inhibitor of miR-155. The invention also provides methods for reducing or inhibiting the proliferation of malignant T cells by administering an oligonucleotide inhibitor of miR-155.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/